Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Xiao Feng Hang
Wen Sheng Xu
Jun Xue Wang
Lei Wang
Hai Guang Xin
Rui Qi Zhang
Wu Ni
机构：
[1] Second Military Medical University,Department of Infectious diseases, Changzheng Hospital
来源：
European Journal of Clinical Pharmacology | 2011年 / 67卷
关键词：
Bevacizumab; Bleeding; Meta-analysis; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：613 / 623
页数：10
相关论文
共 50 条
  • [1] Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials
    Hang, Xiao Feng
    Xu, Wen Sheng
    Wang, Jun Xue
    Wang, Lei
    Xin, Hai Guang
    Zhang, Rui Qi
    Ni, Wu
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (06) : 613 - 623
  • [2] The Incidence and Risk of High-Grade Hypertension in Cancer Patients Treated With Bevacizumab: A Meta-Analysis of Randomized Controlled Studies
    Pulipati, Bhargava C.
    Chu, David
    Wu, Shenghong
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A462 - A462
  • [3] Increased Risk of High-Grade Hemorrhage in Cancer Patients Treated with Gemcitabine: A Meta-Analysis of 20 Randomized Controlled Trials
    Hu, Yi
    Wang, Jingliang
    Tao, Haitao
    Wu, Baishou
    Sun, Jin
    Cheng, Yao
    Dong, Weiwei
    Li, Ruixin
    [J]. PLOS ONE, 2013, 8 (09):
  • [4] Bleeding risk in cancer patients treated with sorafenib: A meta-analysis of randomized controlled trials
    Dai, Chao
    Zhou, Fan
    Shao, Jiang-Hua
    Wu, Lin-Quan
    Yu, Xin
    Yin, Xiang-Bao
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S948 - +
  • [5] Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A. Meta-Analysis
    Ranpura, Vishal
    Pulipati, Bhargava
    Chu, David
    Zhu, Xiaolei
    Wu, Shenhong
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (05) : 460 - 468
  • [6] Risk of bleeding in cancer patients treated with the angiogenesis inhibitor bevacizumab: A meta-analysis
    Sher, A. F.
    Chu, D.
    Wu, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials
    Geiger-Gritsch, Sabine
    Stollenwerk, Bjoern
    Miksad, Rebecca
    Guba, Beate
    Wild, Claudia
    Siebert, Uwe
    [J]. ONCOLOGIST, 2010, 15 (11): : 1179 - 1191
  • [8] Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials
    Zhu, Xiaoqiang
    Tian, Xianglong
    Yu, Chenyang
    Hong, Jie
    Fang, Jingyuan
    Chen, Haoyan
    [J]. MEDICINE, 2016, 95 (34)
  • [9] Meta-Analysis of Randomized Controlled Trials on the Risk of Bleeding With Dabigatran
    Bloom, Benjamin J.
    Filion, Kristian B.
    Atallah, Renee
    Eisenberg, Mark J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (06): : 1066 - 1074
  • [10] Risk of high-grade skin rash in cancer patients treated with panitumumab-A meta-analysis
    Shaker, A.
    Lacouture, M. E.
    Wu, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345